The Washington Post had an interesting column by a doctor that discussed the difficulties his diabetic patients face dealing with the high cost of insulin. While the doctor, David Trigdell, does call for measures by the government to reduce the price that patients and insurers have to pay for the drug, he doesn't ask the most basic questions about why the price is high in the first place.
This gets back to how the government finances medical research. To a large extent it relies on patent mon...
Published on June 25, 2017 00:46